Availability of data and materials
Not applicable.
References
Kreitmann L, Helms J, Martin-Loeches I et al (2024) ICU-acquired infections in immunocompromised patients: a narrative review. Intensive Care Med 50(3):332–349
Tomasello M, Mangioni D, Panigada M et al (2024) Rapid multiplex-PCR panels for the management of ventilator-associated pneumonia: pondering strengths and weaknesses. Intensive Care Med. https://doi.org/10.1007/s00134-024-07375-x
Luyt C-E, Hékimian G, Bonnet I et al (2020) Usefulness of point-of-care multiplex PCR to rapidly identify pathogens responsible for ventilator-associated pneumonia and their resistance to antibiotics: an observational study. Crit Care 24:378. https://doi.org/10.1186/s13054-020-03102-2
Peiffer-Smadja N, Bouadma L, Mathy V et al (2020) Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia. Crit Care 24:366. https://doi.org/10.1186/s13054-020-03067-2
Enne VI, Aydin A, Baldan R et al (2022) Multicentre evaluation of two multiplex PCR platforms for the rapid microbiological investigation of nosocomial pneumonia in UK ICUs: the INHALE WP1 study. Thorax 77:1220–1228. https://doi.org/10.1136/thoraxjnl-2021-216990
Monard C, Pehlivan J, Auger G et al (2020) Multicenter evaluation of a syndromic rapid multiplex PCR test for early adaptation of antimicrobial therapy in adult patients with pneumonia. Crit Care 24:434. https://doi.org/10.1186/s13054-020-03114-y
Murphy CN, Fowler R, Balada-Llasat JM et al (2020) Multicenter evaluation of the BioFire FilmArray Pneumonia/Pneumonia plus panel for detection and quantification of agents of lower respiratory tract infection. J Clin Microb. https://doi.org/10.1128/jcm.00128-20
Navapurkar V, Bartholdson Scott J, Maes M et al (2022) Development and implementation of a customised rapid syndromic diagnostic test for severe pneumonia. Wellcome Open Res 6:256. https://doi.org/10.12688/wellcomeopenres.17099.3
Poulain C, Launey Y, Bouras M et al (2024) Clinical evaluation of the BioFire Respiratory Pathogen Panel for the guidance of empirical antimicrobial therapy in critically ill patients with hospital-acquired pneumonia: a multicenter, quality improvement project. Anaesth Crit Care Pain Med. https://doi.org/10.1016/j.accpm.2024.101353
Kreitmann L, Gaudet A, Nseir S (2023) Ventilator-associated pneumonia in immunosuppressed patients. Antibiotics 12:413. https://doi.org/10.3390/antibiotics12020413
Giovagnorio F, De Vito A, Madeddu G et al (2023) Resistance in Pseudomonas aeruginosa: a narrative review of antibiogram interpretation and emerging treatments. Antibiotics (Basel) 12:1621. https://doi.org/10.3390/antibiotics12111621
Darie AM, Khanna N, Jahn K et al (2022) Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial. Lancet Respir Med 10:877–887. https://doi.org/10.1016/S2213-2600(22)00086-8
Enne V, Stirling S, Barber J et al (2022) LB2304. INHALE WP3: Results of a multi-centre randomised controlled trial (INHALE) testing the utility of rapid multiplex PCR at point-of-care for the antibiotic management of hospital-acquired and ventilator-associated pneumonia in critical care. Open Forum Infect Dis 9:ofac492.1894. https://doi.org/10.1093/ofid/ofac492.1894
University Hospital, Lille (2022) Impact of a strategy based on the Unyvero® testing system on appropriate and targeted antimicrobial treatment in patients with suspected VAP or HAP requiring mechanical ventilation: a randomized controlled unblinded trial. clinicaltrials.gov
University Hospital, Lille (2023) Impact of a strategy based on the PCR testing system on appropriate and targeted antimicrobial treatment in immunocompromised patients with suspected ventilator-associated pneumonia or hospital-acquired pneumonia requiring mechanical ventilation: a randomized controlled unblinded trial. clinicaltrials.gov
Acknowledgements
We thank Frances Davies, Paul Arkell and Zara Breese for their critical appraisal of the manuscript.
Funding
The was no specific funding for this study.
Author information
Authors and Affiliations
Contributions
Study conception and design: LK and SN. Statistical analysis: not applicable. Data curation: not applicable. Manuscript drafting: LK and SN.
Corresponding author
Ethics declarations
Conflicts of interest
LK has received speaking fees and a research scholarship from BioMérieux and has been employed by Transgene. SN has received speaking fees from MSD, Pfizer, BioMérieux, Fischer and Paykel, and Medtronic.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This comment refers to the article available online at https://doi.org/10.1007/s00134-023-07295-2.
Rights and permissions
About this article
Cite this article
Kreitmann, L., Nseir, S. Rapid syndromic multiplex PCR panels for the management of ventilator-associated lower respiratory tract infections: pondering important limitations. Author’s reply. Intensive Care Med 50, 787–788 (2024). https://doi.org/10.1007/s00134-024-07402-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-024-07402-x